1.1. Research Objective

1.2. Product Overview

1.3. Market Segmentation

2.1. Qualitative Research
2.1.1. Primary & Secondary Sources

2.2. Quantitative Research
2.2.1. Primary & Secondary Sources

2.3. Breakdown of Primary Research Respondents, By Region

2.4. Assumption for the Study

2.5. Market Size Estimation

2.6. Data Triangulation

Executive Summary: Global Genomic Testing Market 

4.1. Industry Value Chain Analysis
4.1.1. Raw Material Supplier
4.1.2. Manufacturers
4.1.3. Distributors
4.1.4. End User

4.2. Industry Outlook
4.2.1. Genomic Data Analysis 
4.2.2. Requisite infrastructure and organization for the entering 
4.2.3. Regulatory Landscape W.R.T Region
4.2.3.1. North America Regulations/Laws 
4.2.3.2. Europe Regulations/Laws
4.2.3.3. Asia Pacific Regulations/Laws
4.2.3.4. South America Regulations/Laws
4.2.3.5. Middle East & Africa Regulations/Laws

4.3. PESTLE Analysis

4.4. Porter's Five Forces Analysis
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Power of Buyers
4.4.3. Threat of Substitutes
4.4.4. Threat of New Entrants
4.4.5. Degree of Competition

4.5. Market Dynamics and Trends
4.5.1. Growth Drivers
4.5.2. Restraints
4.5.3. Challenges
4.5.4. Key Trends

4.6. Covid-19 Impact Assessment on Market Growth Trend

4.7. Market Growth and Outlook
4.7.1. Market Revenue Estimates and Forecast (US$ Bn), 2019 - 2032
4.7.2. Price Trend Analysis

4.8. Competition Dashboard
4.8.1. Market Concentration Rate
4.8.2. Company Market Share Analysis (Value %), 2023
4.8.3. Competitor Mapping

5.1. Key Insights

5.2. Market Size and Forecast, 2019 - 2032 (US$ Bn)
5.2.1. System and Software
5.2.2. Reagents & Consumables
5.2.3. Services
5.2.3.1. DTC Genomic Testing Service
5.2.3.2. Sale of genomic data

6.1. Key Insights

6.2. Market Size and Forecast, 2019 - 2032 (US$ Bn)
6.2.1. Sequencing Solution
6.2.1.1. DNA Sequencing
6.2.1.2. RNA Sequencing
6.2.1.3. Methylation Sequencing
6.2.1.4. NGS Library Preparation
6.2.1.5. Sequencing Data Analysis
6.2.1.6. Others
6.2.2. Microarray Solution
6.2.2.1. Human Genotyping with Arrays
6.2.2.2. Non-Human Genotyping with Arrays
6.2.2.3. Methylation Array Analysis
6.2.2.4. Microarray Data Analysis
6.2.2.5. Others

7.1. Key Insights

7.2. Market Size and Forecast, 2019 - 2032 (US$ Bn)
7.2.1. Proteomics 
7.2.2. Pharmacogenomics 
7.2.3. Stem Cell Therapy
7.2.4. Cloning

8.1. Key Insights

8.2. Market Size and Forecast, 2019 - 2032 (US$ Bn)
8.2.1. Cancer
8.2.2. Asthma
8.2.3. Diabetes
8.2.4. Hearth Diseases
8.2.5. Other Indication

9.1. Key Insights

9.2. Market Size and Forecast, 2019 - 2032 (US$ Bn)
9.2.1. Drug Discovery & Development
9.2.2. Disease Diagnosis
9.2.3. Agricultural Production
9.2.4. Others

10.1. Key Insights

10.2. Market Size and Forecast, 2019 - 2032 (US$ Bn)
10.2.1. Hospitals & Clinics
10.2.2. Research Centers & Academic Institutions
10.2.3. Pharmaceutical & Biotechnology Companies
10.2.4. Others

1.1. Key Insights

11.2. Market Size and Forecast, 2019 - 2032 (US$ Bn)
11.2.1. By Offering, By Application, By End User

12.1. Key Insights

12.2. Market Size and Forecast, 2019 - 2032 (US$ Bn)
12.2.1. North America
12.2.1.1. The U.S.
12.2.1.2. Canada
12.2.1.3. Mexico
12.2.2. Europe
12.2.2.1. Western Europe
12.2.2.1.1. The UK
12.2.2.1.2. Germany
12.2.2.1.3. France
12.2.2.1.4. Italy
12.2.2.1.5. Spain
12.2.2.1.6. Rest of Western Europe
12.2.2.2. Eastern Europe
12.2.2.2.1. Poland 
12.2.2.2.2. Russia
12.2.2.2.3. Rest of Eastern Europe
12.2.3. Asia Pacific
12.2.3.1. China
12.2.3.2. India
12.2.3.3. Japan
12.2.3.4. South Korea
12.2.3.5. Australia & New Zealand
12.2.3.6. ASEAN
12.2.3.7. Rest of Asia Pacific
12.2.4. Middle East & Africa
12.2.4.1. UAE
12.2.4.2. Saudi Arabia
12.2.4.3. South Africa
12.2.4.4. Rest of MEA
12.2.5. South America
12.2.5.1. Argentina
12.2.5.2. Brazil
12.2.5.3. Rest of South America

13.1. Key Insights

13.2. Market Size and Forecast, 2019 - 2032 (US$ Bn)
13.2.1. By Offering
13.2.2. By Testing Type
13.2.3. By Technology
13.2.4. By Indication
13.2.5. By Application
13.2.6. By End User
13.2.7. Cross Analysis
13.2.8. By Country

14.1. Key Insights

14.2. Market Size and Forecast, 2019 - 2032 (US$ Bn)
14.2.1. By Offering
14.2.2. By Testing Type
14.2.3. By Technology
14.2.4. By Indication
14.2.5. By Application
14.2.6. By End User
14.2.7. Cross Analysis
14.2.8. By Country

15.1. Key Insights

15.2. Market Size and Forecast, 2019 - 2032 (US$ Bn)
15.2.1. By Offering
15.2.2. By Testing Type
15.2.3. By Technology
15.2.4. By Indication
15.2.5. By Application
15.2.6. By End User
15.2.7. Cross Analysis
15.2.8. By Country

16.1. Key Insights

16.2. Market Size and Forecast, 2019 - 2032 (US$ Bn)
16.2.1. By Offering
16.2.2. By Testing Type
16.2.3. By Technology
16.2.4. By Indication
16.2.5. By Application
16.2.6. By End User
16.2.7. Cross Analysis

17.1. Key Insights

17.2. Market Size and Forecast, 2019 - 2032 (US$ Bn)
17.2.1. By Offering
17.2.2. By Testing Type
17.2.4. By Indication
17.2.5. By Application
17.2.6. By End User
17.2.7. Cross Analysis

18.1. Key Insights

18.2. Market Size and Forecast, 2019 - 2032 (US$ Bn)
18.2.1. By Offering
18.2.2. By Testing Type
18.2.3. By Technology
18.2.4. By Indication
18.2.5. By Application
18.2.6. By End User
18.2.7. Cross Analysis
18.2.8. By Country

19.1. Key Insights

19.2. Market Size and Forecast, 2019 - 2032 (US$ Bn)
19.2.1. By Offering
19.2.2. By Testing Type
19.2.3. By Technology
19.2.4. By Indication
19.2.5. By Application
19.2.6. By End User
19.2.7. Cross Analysis

20.1. Key Insights

20.2. Market Size and Forecast, 2019 - 2032 (US$ Bn)
20.2.1. By Offering
20.2.2. By Testing Type
20.2.3. By Technology
20.2.4. By Indication
20.2.5. By Application
20.2.6. By End User
20.2.7. Cross Analysis
20.2.8. By Country

21.1. Key Insights

21.2. Market Size and Forecast, 2019 - 2032 (US$ Bn)
21.2.1. By Offering
21.2.2. By Testing Type
21.2.3. By Technology
21.2.4. By Indication
21.2.5. By Application
21.2.6. By End User
21.2.7. Cross Analysis

22.1. Agilent Technologies, Inc.
22.2. BGI Group
22.3. Bio-Rad Laboratories
22.4. Danaher Corporation
22.5. Eurofins Genomics 
22.6. F. Hoffmann-La Roche
22.7. Illumina, Inc.
22.8. QIAGEN 
22.9. Singular Genomics Systems, Inc.
22.10. Thermo Fisher Scientific, Inc.
22.11. Other Prominent players